Simplex Trading, LLC Ventyx Biosciences, Inc. Transaction History
Simplex Trading, LLC
- $3.28 Billion
- Q4 2024
A detailed history of Simplex Trading, LLC transactions in Ventyx Biosciences, Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 149,554 shares of VTYX stock, worth $255,737. This represents 0.01% of its overall portfolio holdings.
Number of Shares
149,554Holding current value
$255,737% of portfolio
0.01%Shares
4 transactions
Others Institutions Holding VTYX
# of Institutions
136Shares Held
60.3MCall Options Held
62.3KPut Options Held
127K-
Black Rock Inc. New York, NY4.77MShares$8.16 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il4.48MShares$7.66 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC4.27MShares$7.31 Million0.0% of portfolio
-
Sio Capital Management, LLC New York, NY4.05MShares$6.92 Million3.31% of portfolio
-
Ubs Group Ag3.78MShares$6.47 Million0.0% of portfolio
About Ventyx Biosciences, Inc.
- Ticker VTYX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,527,200
- Market Cap $96.7M
- Description
- Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment of immune-mediated diseases, such as psoriasis...